Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents
Clinical trial NCT00485264 · COMPLETED
Trial details
- NCT number
- NCT00485264
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-17
- Primary completion
- 2013-06-03
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.